Skip to content
value.today
Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX
$199 Mmarket cap on Oct 28, 2026+201.9% since Jan 2024
Compare
World rank
#16,259
Revenue
$78 M
For year ending June-2026
Net income
$14 M
17.6% margin
SEC filing
Employees
206
As of June 30, 2026
SEC filing

Pro-Dex, Inc. in brief

Pro-Dex, Inc. is a listed company in the Medical Instruments industry, based in Irvine, California, USA. Its market value was $199 M on 28 October 2026, which makes it the 16,259th largest listed company in the world and the 3,154th largest in the USA on this site. In the year to June 2026 it had sales of $78 M and a net profit of $14 M, about 18 cents of profit for every dollar of sales. It employs about 206 people and Richard Lee Van Kirk Jr. is its chief executive. Its shares trade under the symbol PDEX (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Pro-Dex, Inc.

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions that appeal to our customers, primarily medical device distributors. Additionally, we provide engineering, quality and regulatory consulting services to our customers. We also manufacture and sell rotary air motors to a wide range of industries; however, these motors comprise a de minimis portion of our business. Beginning in fiscal 2026, we began selling precision machined parts and assemblies for the aerospace and defense industries through our newly acquired subsidiary, Advanced Precision Machining, LLC.

From the company's annual report filed with the US SEC: read the report

Pro-Dex, Inc. timeline

3 events, 1995–2026
  1. 1995
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2026
  4. 💰
    Record revenue of $78 million
    FY2026, the highest of the 9 years on record.
  5. 💰
    Record net income of $14 million
    FY2026, the highest profit of the 9 years on record.

Events of Pro-Dex, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$58 M$116 M$173 M$231 M2020202120222023202420252026

World rank over time

▲ up 3,991 places since 2020
2020-01-01: #20303#20,30320202021-01-01: #17429#17,42920212022-01-07: #23562#23,56220222022-12-25: #24378#24,37820222023-07-30: #23890#23,89020232024-01-05: #23554#23,55420242026-03-08: #9455#9,45520262026-08-01: #15215#15,21520262026-10-09: #16353#16,35320262026-10-28: #16312#16,3122026

Rank in USA: #3,915 (Jan 2020) · #3,574 (Jan 2021) · #4,501 (Jan 2022) · #4,669 (Dec 2022) · #4,554 (Jul 2023) · #3,928 (Jan 2024) · #1,821 (Mar 2026) · #3,070 (Aug 2026) · #3,138 (Oct 2026) · #3,158 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
16.6×
Price / sales (TTM)
2.5×
Price / book
4.2×
Free cash flow yield
3.4%
Net margin (TTM)
15.1%
Operating margin
16.8%
Return on equity
25.3%
Liabilities / assets
36.1%
Net debt
$9M
Revenue growth
+16.5%
R&D / revenue
4.3%
Revenue per employee
$376 K
Profit per employee
$66 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue $27M, net income $4M$27MFY19Fiscal year ending Jun 2020: revenue $35M, net income $6M$35MFY20Fiscal year ending Jun 2021: revenue $38M, net income $6M$38MFY21Fiscal year ending Jun 2022: revenue $42M, net income $5M$42MFY22Fiscal year ending Jun 2023: revenue $46M, net income $7M$46MFY23Fiscal year ending Jun 2024: revenue $54M, net income $2M$54MFY24Fiscal year ending Jun 2025: revenue $67M, net income $9M$67MFY25Fiscal year ending Jun 2026: revenue $78M, net income $14M$78MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026$78M+16.5%$13M$14M17.6%
Jun 2025$67M+23.7%$11M$9M13.5%
Jun 2024$54M+16.8%$7M$2M4.0%
Jun 2023$46M+9.6%$6M$7M15.3%
Jun 2022$42M+10.5%$5M$5M10.9%
Jun 2021$38M+9.2%$5M$6M16.2%
Jun 2020$35M+28.2%$7M$6M17.5%
Jun 2019$27M—$5M$4M15.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$7M$0M$7M$4.12—
Jun 2025$-2M$1M$-3M$2.67—
Jun 2024$6M——$0.60—
Jun 2023$5M——$1.95—
Jun 2022$-1M$2M$-2M$1.21—
Jun 2021$-2M$2M$-4M$1.57—
Jun 2020$5M$1M$4M$1.50—
Jun 2019$3M$1M$2M$0.97—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$80M
Net income, trailing 12 months
$12M
RevenueNet income
Three months to Dec 2024: revenue $17M, net income $2M$17MDec ’24Three months to Mar 2025: revenue $17M, net income $3M$17MMar ’25Three months to Jun 2025 (from the annual report): revenue $18M, net income $1M$18MJun ’25Three months to Sep 2025: revenue $19M, net income $5M$19MSep ’25Three months to Dec 2025: revenue $19M, net income $2M$19MDec ’25Three months to Mar 2026: revenue $20M, net income $4M$20MMar ’26Three months to Jun 2026 (from the annual report): revenue $20M, net income $3M$20MJun ’26Three months to Sep 2026: revenue $21M, net income $3M$21MSep ’26

Latest quarter to Sep 2026: revenue $21M (+11.0% on a year earlier), net income $3M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Pro-Dex, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$78 M
Operating income
$13 M
Net income
$14 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$75 M
Total liabilities
$27 M
Total equity
$48 M

As of June-2026

Top 85 institutional investors in Pro-Dex, Inc.#

As of Sep 30, 2026
85 institutions held 1.0 M shares (about 32.4% of the shares outstanding) on Sep 30, 2026. The ten largest hold 19.1%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Pro-Dex, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.156,094+2,916 (+1.90%)4.88%$11 MNov 13, 2026
2Global Retirement Partners, LLC78,901+77,901 (+7790.10%)2.47%$5 MNov 10, 2026
3Vanguard Capital Management LLC77,491-4,792 (-5.82%)2.42%$5 MNov 13, 2026
4Dimensional Fund Advisors LP62,633+5,572 (+9.76%)1.96%$4 MNov 4, 2026
5Punch & Associates Investment Management, Inc.50,437-2,298 (-4.36%)1.58%$3 MNov 16, 2026
6Geode Capital Management, LLC48,927-709 (-1.43%)1.53%$3 MNov 6, 2026
7State Street Corp38,698+7,388 (+23.60%)1.21%$3 MNov 12, 2026
8D. E. Shaw & Co., Inc.37,484New1.17%$3 MNov 16, 2026
9Jpmorgan Chase & Co32,540+253 (+0.78%)1.02%$2 MNov 12, 2026
10Uniplan Investment Counsel, Inc.28,339New0.89%$2 MNov 12, 2026
11Lazard Asset Management LLC23,537New0.74%$2 MNov 16, 2026
12Pekin Hardy Strauss, Inc.22,800+6,300 (+38.18%)0.71%$2 MNov 2, 2026
13Apriem Advisors20,070New0.63%$1 MNov 16, 2026
14Goldman Sachs Group Inc19,945+1,234 (+6.60%)0.62%$1 MNov 16, 2026
15Arrowstreet Capital, Limited Partnership17,393New0.54%$1 MNov 13, 2026
16Ellsworth Advisors, LLC16,904New0.53%$1 MOct 15, 2026
17Bank of New York Mellon Corp15,530+3,943 (+34.03%)0.49%$1 MNov 5, 2026
18Northern Trust Corp15,528-87 (-0.56%)0.49%$1 MNov 16, 2026
19Vanguard Portfolio Management LLC14,476+144 (+1.00%)0.45%$1 MNov 13, 2026
20Quadrature Capital Ltd13,801New0.43%$1 MNov 13, 2026
21Vanguard Fiduciary Trust Co12,493-807 (-6.07%)0.39%$1 MNov 13, 2026
22Squarepoint Ops LLC11,656New0.36%$1 MNov 9, 2026
23Russell Investments Group, Ltd.11,191+10,466 (+1443.59%)0.35%$1 MNov 6, 2026
24Corsair Capital Management, L.P.10,8350 (0.00%)0.34%$1 MNov 16, 2026
25Morgan Stanley10,586+1,922 (+22.18%)0.33%$1 MNov 13, 2026
Show all 85: investors 26 to 85
Institutional investors 26 to 85 in Pro-Dex, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26LPL Financial LLC10,562-3,735 (-26.12%)0.33%$1 MNov 6, 2026
27Millennium Management LLC10,364+5,587 (+116.96%)0.32%$1 MNov 16, 2026
28Bard Associates Inc9,893+94 (+0.96%)0.31%$1 MNov 13, 2026
29O'shaughnessy Asset Management, LLC9,286+4,205 (+82.76%)0.29%$1 MNov 12, 2026
30Osaic Holdings, Inc.8,780-280 (-3.09%)0.27%$1 MNov 12, 2026
31BNP Paribas Financial Markets8,708-7,237 (-45.39%)0.27%$1 MNov 12, 2026
32Acadian Asset Management LLC8,338+8,079 (+3119.31%)0.26%$1 MNov 9, 2026
33Point72 Asset Management, L.P.8,200New0.26%$1 MNov 16, 2026
34First Trust Advisors LP7,487+1,553 (+26.17%)0.23%$1 MNov 12, 2026
35Ritholtz Wealth Management7,288+2,668 (+57.75%)0.23%$1 MNov 5, 2026
36HRT Financial LP7,070-2,444 (-25.69%)0.22%$0 MNov 13, 2026
37Charles Schwab Investment Management Inc6,567-514 (-7.26%)0.21%$0 MNov 16, 2026
38Qube Research & Technologies Ltd6,500New0.20%$0 MNov 13, 2026
39Nuveen, LLC5,367-3,880 (-41.96%)0.17%$0 MNov 10, 2026
40Morgan Dempsey Capital Management LLC5,190-1,526 (-22.72%)0.16%$0 MNov 13, 2026
41Ameriprise Financial Inc5,174New0.16%$0 MNov 16, 2026
42Navellier & Associates Inc5,138-358 (-6.51%)0.16%$0 MNov 12, 2026
43Bridgeway Capital Management, LLC5,000New0.16%$0 MNov 16, 2026
44Integrated Quantitative Investments LLC4,709New0.15%$0 MNov 13, 2026
45UBS Group AG4,280-352 (-7.60%)0.13%$0 MNov 10, 2026
46Strs Ohio4,100New0.13%$0 MOct 30, 2026
47AQR Capital Management LLC3,616New0.11%$0 MNov 16, 2026
48Greenhaven Road Investment Management, L.P.3,5850 (0.00%)0.11%$0 MNov 13, 2026
49Alliancebernstein L.P.3,500New0.11%$0 MNov 16, 2026
50NewEdge Advisors, LLC3,004New0.09%$0 MNov 13, 2026
51James Investment Research, Inc.3,000New0.09%$0 MOct 22, 2026
52Focus Financial Network, Inc.3,000New0.09%$0 MOct 14, 2026
53Jain Global LLC2,905New0.09%$0 MNov 16, 2026
54Vanguard Global Advisers, LLC2,690+1,666 (+162.70%)0.08%$0 MNov 13, 2026
55Los Angeles Capital Management LLC2,650New0.08%$0 MNov 12, 2026
56Rhumbline Advisers2,476+974 (+64.85%)0.08%$0 MNov 10, 2026
57Royal Bank Of Canada1,765+455 (+34.73%)0.06%$0 MNov 16, 2026
58Deutsche Bank AG\1,613-218 (-11.91%)0.05%$0 MNov 6, 2026
59Citigroup Inc1,264+291 (+29.91%)0.04%$0 MNov 4, 2026
60New York State Common Retirement Fund1,0900 (0.00%)0.03%$0 MNov 17, 2026
61MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.1,005+50 (+5.24%)0.03%$0 MNov 16, 2026
62Barclays PLC768+463 (+151.80%)0.02%$0 MNov 6, 2026
63Police & Firemen's Retirement System of New Jersey6370 (0.00%)0.02%$0 MNov 9, 2026
64Wells Fargo & Company/mn630-1,261 (-66.68%)0.02%$0 MNov 16, 2026
65FMR LLC374+118 (+46.09%)0.01%$0 MNov 10, 2026
66Lavaca Capital LLC240-113 (-32.01%)0.01%$0 MNov 16, 2026
67Ameritas Investment Partners, Inc.2160 (0.00%)0.01%$0 MNov 13, 2026
68Legal & General Group Plc1920 (0.00%)0.01%$0 MNov 16, 2026
69Tower Research Capital LLC (TRC)175-175 (-50.00%)0.01%$0 MNov 16, 2026
70Arax Advisory Partners126-85 (-40.28%)0.00%$0 MNov 12, 2026
71Ascentis Independent Advisors120New0.00%$0 MNov 3, 2026
72Harbour Investments, Inc.1000 (0.00%)0.00%$0 MNov 9, 2026
73PNC Financial Services Group, Inc.96+70 (+269.23%)0.00%$0 MNov 6, 2026
74Sterling Capital Management LLC68+61 (+871.43%)0.00%$0 MOct 22, 2026
75Hurley Capital, LLC600 (0.00%)0.00%$0 MNov 5, 2026
76Allworth Financial LP35+29 (+483.33%)0.00%$0 MNov 17, 2026
77SJS Investment Consulting Inc.33+29 (+725.00%)0.00%$0 MOct 26, 2026
78California State Teachers Retirement System290 (0.00%)0.00%$0 MNov 13, 2026
79GAMMA Investing LLC180 (0.00%)0.00%$0 MOct 8, 2026
80Root Financial Partners, LLC12New0.00%$0 MOct 21, 2026
81Farther Finance Advisors, LLC10-1 (-9.09%)0.00%$0 MOct 8, 2026
82Physician Wealth Advisors, Inc.9New0.00%$0 MOct 20, 2026
83Essential Partners LLC70 (0.00%)0.00%$0 MOct 14, 2026
84EverSource Wealth Advisors, LLC2-1 (-33.33%)0.00%$0 MNov 4, 2026
85True Wealth Design, LLC10 (0.00%)0.00%$0 MOct 13, 2026

Mutual funds holding Pro-Dex, Inc.#

74 funds hold shares worth $19 M (about 10.1% of the company). Since their previous reports 24 added shares and 15 sold, selling $1 M net.
Mutual funds holding Pro-Dex, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.60,523$4 M1.9%<0.01%−32%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors53,550$3 M1.7%<0.01%−4.9%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC22,677$1 M0.71%<0.01%+9.8%Jul 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP21,926$1 M0.69%<0.01%no changeJul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors20,554$1 M0.64%<0.01%+14%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.19,706$1 M0.62%<0.01%−0.4%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.10,648$1 M0.33%<0.01%+1.7%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC9,341$1 M0.29%<0.01%−6.2%May 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC8,195$0 M0.26%<0.01%newJun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP7,809$0 M0.24%<0.01%+2.5%Jul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors6,982$0 M0.22%0.03%+33%Jun 30, 2026
🇺🇸 First Trust Dow Jones Select MicroCap Index FundFirst Trust Advisors L.P.5,934$0 M0.19%0.13%+3.9%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.5,165$0 M0.16%<0.01%+13%Jul 31, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP5,042$0 M0.16%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP4,857$0 M0.15%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC4,064$0 M0.13%<0.01%no changeMay 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC3,665$0 M0.11%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP3,580$0 M0.11%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC3,119$0 M0.10%0.02%newJul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC2,777$0 M0.09%<0.01%−7.5%May 31, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.2,883$0 M0.09%0.05%no changeJul 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC2,739$0 M0.09%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP2,725$0 M0.09%<0.01%no changeJul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC2,354$0 M0.07%<0.01%no changeJun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC2,200$0 M0.07%<0.01%+57%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC1,984$0 M0.06%<0.01%−42%May 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust1,974$0 M0.06%<0.01%+236%May 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.1,909$0 M0.06%<0.01%−4.2%May 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC1,926$0 M0.06%<0.01%+22%Jun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.1,916$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation1,500$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP1,452$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,300$0 M0.04%<0.01%+160%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust1,065$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.1,148$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC1,002$0 M0.03%<0.01%+13%Jul 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.972$0 M0.03%<0.01%−7.3%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company860$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.906$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP810$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.700$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP643$0 M0.02%<0.01%newJul 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP640$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.558$0 M0.02%0.01%newJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC556$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.550$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC478$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC467$0 M0.01%0.01%+23%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC424$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS392$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP344$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC338$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.302$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION300$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.328$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.313$0 M<0.01%<0.01%+57%Jun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC307$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC261$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC240$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.233$0 M<0.01%<0.01%+0.9%Jul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management216$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC212$0 M<0.01%<0.01%+48%Jun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS184$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC179$0 M<0.01%<0.01%+13%Jul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC175$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC100$0 M<0.01%<0.01%newMay 31, 2026
🇺🇸 Avantis U.S. Small Cap Value FundAmerican Century ETF Trust100$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC98$0 M<0.01%<0.01%+4.3%May 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC108$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC79$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC79$0 M<0.01%<0.01%−41%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC77$0 M<0.01%<0.01%−41%May 31, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.36$0 M<0.01%<0.01%−51%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.12$0 M<0.01%<0.01%+20%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 74 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Pro-Dex, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$2.0 M
20 sales, 3 insiders
Net, 12 months
-$2.0 M
open market only
Insiders on file
14
since
-$2.0 M$0Jun 2024: bought $0 (0 trades), sold $47 K (1 trades)Jun 24Nov 2024: bought $0 (0 trades), sold $40 K (1 trades)NovJan 2025: bought $0 (0 trades), sold $1.8 M (17 trades)Jan 25Mar 2025: bought $0 (0 trades), sold $2.0 M (11 trades)MarApr 2025: bought $0 (0 trades), sold $363 K (3 trades)AprMar 2026: bought $0 (0 trades), sold $47 K (1 trades)MarMay 2026: bought $0 (0 trades), sold $626 K (6 trades)MaySep 2026: bought $0 (0 trades), sold $1.4 M (13 trades)Sep
Bought (open market)Sold (open market)Hover a month for the totals
Pro-Dex, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-290$58.94$17 K79,703Form 4
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-475$59.62$28 K79,228Form 4
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-2,160$58.92$127 K97,068Form 4
filed Alisha CharltonChief Financial OfficerSell-1,500$61.05$92 K22,670Form 4
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-2,691$59.84$161 K94,377Form 4
filed Alisha CharltonChief Financial OfficerSell-800$61.76$49 K21,870Form 4
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-4,274$60.72$260 K90,103Form 4
filed Richard Lee Van Kirk Jr.Chief Executive Officer, DirectorSell10b5-1 plan-1,157$61.88$72 K88,946Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Pro-Dex, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
271,336
8.5% of shares · 7.42 days to cover
Buybacks, Q3 2026
$0.6M
Q1 2027
Shares sold short, last 24 reportsAll stocks →
Pro-Dex, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q1 2027$0.6M
Q2 2026Q4 2026$0.6M
Q1 2026Q3 2026$0.6M
Q2 2025Q4 2025$0M
Q1 2025Q3 2025$0M
Q4 2024Q2 2025$1.2M
Q3 2024Q1 2025$2.3M
Q2 2024Q4 2024$1.7M
Q1 2024Q3 2024$1.7M
Q2 2023Q4 2023$0M
Q1 2023Q3 2023$0.2M
Q4 2022Q2 2023$1M
Q3 2022Q1 2023$0.4M
Q2 2022Q4 2022$0.4M
Q1 2022Q3 2022$0.6M
Q4 2021Q2 2022$0.6M

Trading halts

  • 2025-05-02 13:34 UTC, code LUDP, resumed 13:39 UTC

Fails to deliver

  • : 1,406 shares at $62.27
  • : 222 shares at $57.70
  • : 92 shares at $58.26
  • : 364 shares at $60.02
  • : 638 shares at $59.82

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Pro-Dex, Inc. scorecard#

Passes 22 of the 27 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (3 of 6). Fiscal year 2026; market cap of Oct 28, 2026.

  • Valuation3 of 6
    • ✓P/E below its peers' median16.6×P/E 16.6× against Medical Instruments's median of 32.6×.
    • ✗Price to book below its peers' median4.2×Price to book 4.2× against Medical Instruments's median of 3.9×.
    • ✓Price to sales below its peers' median2.5×Price to sales 2.5× against Medical Instruments's median of 3.0×.
    • ✗Free cash flow yield above 5%3.4%Free cash flow is 3.4% of the market value.
    • ✓Earnings yield above the 10-year Treasury yield6.0%Earnings yield 6.0% against the 10-year Treasury's 5.15% on 2026-11-13.
    • ✗The price assumes slower growth than the last three years'31.5%The price assumes 31.5% a year for ten years; revenue grew 18.9% a year over the last three.
  • Growth6 of 6
    • ✓Revenue grew in the newest year16.5%Revenue up 16.5% in fiscal 2026.
    • ✓Revenue up more than 5% a year over three years18.9%18.9% a year over the three years to fiscal 2026.
    • ✓Faster growth over three years than its peers' median18.9%18.9% a year against Medical Instruments's median of 5.0% (37 companies).
    • ✓Earnings per share grew in the newest year4.12 vs 2.67Diluted EPS 4.12 in fiscal 2026 against 2.67 the year before (report's currency).
    • ✓Net income higher than five years earlier$14 M$14 M in fiscal 2026 against $6 M in 2021.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2026.
  • Profitability6 of 6
    • ✓Profitable in the newest year$14 MNet income $14 M in fiscal 2026.
    • ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2026.
    • ✓Operating margin above its peers' median16.8%16.8% against Medical Instruments's median of 7.2% (46 companies).
    • ✓Return on equity above 15%32.4%32.4% in fiscal 2026.
    • ✓Return on invested capital above 10%18.1%18.1% in fiscal 2026.
    • ✓Operating margin wider than three years earlier16.8%16.8% in fiscal 2026 against 12.5% in 2023.
  • Financial health5 of 6
    • ✓Short-term assets cover short-term liabilities4.1×Current ratio 4.10 at the end of fiscal 2026.
    • ✓Debt below equity0.4×Debt to equity 0.37 at the end of fiscal 2026.
    • ✓Net debt below three years of EBITDA0.7×Net debt 0.7 times EBITDA in fiscal 2026.
    • ✓Operating income covers interest five times16.0×Operating income 16.0 times interest in fiscal 2026.
    • ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2026.
    • ✓Altman Z-score outside the distress zone7.61Z-score 7.61 (safe zone) for fiscal 2026.
  • Shareholder returns2 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-1.3%Diluted shares down 1.3% in fiscal 2026.
    • ✗Dividends and buybacks above 3% of the market value1.7%Dividends and buybacks were 1.7% of the market value.
    • ✓Free cash flow covers dividends and buybacks$7 MFree cash flow $7 M against $3 M paid out in fiscal 2026.

Worked out from the statements as filed (sec), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2026#

Worked out from Pro-Dex, Inc.'s statements, beside the median of Medical Instruments.

Pro-Dex, Inc.: main financial ratios in 2026
Ratio2026Median of peers
Operating margin16.8%7.2%
Net margin17.6%3.8%
Return on equity32.4%3.5%
Revenue growth, 3 years a year18.9%5.0%
Revenue growth16.5%8.9%
Debt to equity0.37×0.46×

7of 9on the Piotroski tests of financial strength

  • Revenue has grown 12 years in a row.

Pro-Dex, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Pro-Dex, Inc.: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Revenue77,54866,59353,84446,08742,04138,02934,83427,17222,46521,943
Cost of revenue53,21347,08339,29333,33828,90924,45421,69217,39214,52214,757
Gross profit24,33519,51014,55112,74913,13213,57513,1429,7807,9437,186
Research and development3,3453,6363,1892,8042,9804,3842,3151,8821,8931,225
Selling, general and administrative7,9995,185————————
Selling and marketing—34411715591590577415358585
General and administrative—4,8414,0724,0284,9034,0763,1892,4922,2872,529
Operating expenses11,3448,8217,3786,9878,0099,0506,0764,7825,5514,449r
Operating income12,99110,6897,1735,7625,1234,5257,0664,9982,3922,737r
Interest and finance income18182144294761269526822527
Interest expense and finance costs8128295585334643522362207.012
Share of profit of associates————61—————
Other non-operating income (expense)5,0241,369−4,5393,666571r3,091r83644921815r
Income before tax18,01512,0582,6349,4285,694r7,616r7,9025,4472,6102,752
Income tax4,3533,0805072,3541,122r1,446r1,7901,299989−2,089
Income from continuing operations————————1,6214,841
Income from discontinued operations—————————243
Net income including minority interests0155118108071370———
Net income attributable to shareholders13,6628,9782,1277,0744,572r6,170r6,1124,1481,6215,084
Earnings per share, basic4.242.730.611.981.26r1.63r1.560.990.381.26
Earnings per share, diluted4.122.670.601.951.21r1.57r1.500.970.371.25
Shares, weighted average (basic)3.23.33.53.63.63.83.94.24.34.0
Shares, weighted average (diluted)3.33.43.63.63.83.94.14.34.34.1
Balance sheet
Cash and cash equivalents8,192419r2,631r2,9368493,7216,4217,7425,1884,205
Short-term investments1,1506,7404,2171,1347551,295r2,5601,711r2,220718
Receivables21,20516,43313,8879,95215,38410,9335,1554,1002,9553,538
Inventory21,45822,21315,26916,16712,6788,4378,2386,2394,3933,084r
Other current assets—410345296790434145623269363
Current assets53,24847,29536,61130,97931,16625,01322,67420,845r16,23312,283r
Property, plant and equipment5,3735,1535,024r5,0794,8333,8452,6862,7261,7551,350r
Right-of-use (leased) assets6021,0501,4731,8722,2482,6052,943———
Goodwill6,525————————112
Other intangible assets686265481118186162129140149r
Long-term investments5041481,5637,5214,083r1,7042,3601,520r——
Total assets74,50961,19252,47751,82349,089r40,32031,12625,52019,91716,351
Accounts payable4,2624,6144,5132,2613,7612,2881,9651,9961,0831,159
Debt due within a year—————1,2366516223558
Current liabilities12,98314,62912,8929,67611,3546,269r5,2274,2702,415r2,580
Long-term debt—————11,5353,2833,9346.061
Lease liabilities (non-current)6276851,1821,6382,0542,4322,750———
Non-current liabilities13,8939,9318,71810,55712,30413,967r6,8374,242226r61
Total liabilities26,87624,56021,61020,23323,65820,23612,0648,5122,6412,641
Retained earnings47,63335,92826,95024,82317,749r12,131r7,8961,742−2,406−4,027
Shareholders' equity47,63336,63230,86731,59025,431r21,130r19,06217,00817,27613,710
Total liabilities and equity74,50961,19252,47751,82349,089r40,32031,12625,52019,91716,351
Shares outstanding3.23.33.43.53.63.63.6r4.04.34.0
Cash-flow statement
Depreciation and amortization1,3941,2391,160857726686573438557555
Share-based compensation6885556057661,275901286371943.0
Cash from operating activities7,242−1,6826,224r5,462−847−2,0784,9453,3263,0963,235
Capital expenditure−483−1,246——−1,638−1,769−519−1,387−923−606
Intangible assets bought————−33−38−46−11−11−32
Acquisitions, net of cash acquired−6,493—————————
Cash from investing activities3,913−238−2,233−885−1,235−3,710−2,287−1,222−4,115−1,026
Debt issued———5,2842,0009,139—4,940——
Shares issued————————2,26248
Shares bought back−3,408−3,504−3,505−1,547−1,606−5,537−3,388−3,984−220−312
Cash from financing activities−3,382−292−4,296r−2,490−7903,088−3,9794502,002−298
Change in cash———————2,5549831,911
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Executive pay at Pro-Dex, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$728 K
Rick
Other top executives, average
$354 K
the CEO earned 2.1× this
$100 invested is now
$307
Pro-Dex, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Rick$728 K$1.1 M$354 K$307
2025Rick$653 K$1.9 M$358 K$226
2024Rick$441 K$397 K$321 K$103

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026

Events at Pro-Dex, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling

Auditor changed 1 · Acquisition or sale completed 1 · Directors and officers 8 · Material agreement 6 · New debt 4 · Shareholder vote 2 · Results announced 10

Pro-Dex, Inc.: events reported to the SEC
FiledWhat happenedFiling
Material agreement8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Acquisition or sale completedMaterial agreementNew debt8-K
Results announced8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Auditor changed8-K
Results announced8-K
Material agreementNew debt8-K
Results announced8-K
Material agreementNew debt8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Material agreementNew debt8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Oct 30, 2026

H-1B hiring at Pro-Dex, Inc.#

1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $115 K a year.

Certified, FY2026
1
#1,893 among companies on value.today
Worker positions
1
Median wage offered
$115 K
a year, full-time
Applications filed
1
Pro-Dex, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
VALIDATION SUPERVISORValidation Engineers1$115 K

Where: Tustin, CA 1

Pro-Dex, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202611$115 K1
FY202311$105 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Pro-Dex, Inc.

Product recalls by Pro-Dex, Inc.#

5 recalls since 2015, 6,262 units in the notices that give a number. Medical devices (FDA): 5.

Pro-Dex, Inc.: product recalls
DateWhat and whyUnitsNotice
KLS Martin Battery Pack, REF: KLS BP2 001, and KLS BP2 040 (bulk case of 40), used in conjunction with the KLS Martin MaxDriver 2.0 surgical driver, REF: KLS-SD-2000The packaging of a sterile battery, intended to power a surgical screwdriver, may contain Tyvek shavings inside the sterile package.Medical devicesClass II2,000Z-0280-2025
KLS Martin Battery Pack, REF: KLS BP 001, and KLS BP 040 (bulk case of 40), used in conjunction with the KLS Martin MaxDriverBattery packs used in surgical procedures where a surgeon uses a powered screwdriver and a right-angle attachment have switched manufacturing and expiration dates on sterile pouch labels, so batteries will appear to be prematurely expired.Medical devicesClass II2,000Z-2098-2023
KLS martin Group KLS E-COUPLING ADAPTER REF PDEC-1000-2 E-Coupling Adapter Assembly used to connect the KLS driver (e.g. drill) to a driver bit that fits into the adapter.Incorrect Unique Device Identifier/GTIN code was used on product.Medical devicesClass II199Z-1391-2023
PRO-DEX Surgical Driver Battery Pack PDBP-001 Series PRO-DEX Battery Pack, Single Pouch - PDBP-001-2 PRO-DEX Battery Pack, 40 Pouches - PDBP-040-2 Product Usage: -The PDBP-001 Battery is a single use (non-rechargeable) sterile lithium ion battery accessory that powers the PDSD Surgical driver. There is only one PDSD Surgical dr…Visual particulates within a battery Tyvek pouch. The battery is provided sterile for use with surgical drivers.Medical devicesClass II68Z-2340-2019
Battery Pack KLS-SD-1000 Single Models: KLS-BP-001 Used to power the KLS Martin Max Driver (battery powdered surgical screwdriver). (and 1 more products)The sterile battery may contain particulates within the sterile package.Medical devicesClass II1,995Z-1095-2016

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

Layoffs at Pro-Dex, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
0
2012–2012
Latest
—
2012-02-27
Pro-Dex, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2012············—
Pro-Dex, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
Not statedRestructuring planSEC 8-KCompany-wide planFiling

Source: State WARN notices and SEC 8-K item 2.05

How Pro-Dex, Inc. compares in Medical Instruments

  • Market cap$199 M · higher than 24% of 116
  • Revenue$78 M · higher than 16% of 120
  • Net margin15.1% · higher than 73% of 114
  • Revenue growth16.5% · higher than 77% of 49
  • P/E ratio16.6× · lower than 82% of 68
  • Price / sales2.5× · lower than 60% of 85
  • Price / book4.2× · lower than 40% of 84
  • FCF yield3.4% · higher than 68% of 39

Peer comparison · Medical Instruments

CompanyMarket capP/ENet marginRev. growth
Pro-Dex, Inc.🇺🇸$199 M16.6×15.1%+16.5%
Intuitive Surgical, Inc.🇺🇸$155.6 B52.6×25.5%+20.5%
EssilorLuxottica S.A.🇫🇷$88.0 B32.1×8.1%+4.5%
HOYA Corporation🇯🇵$56.2 B32.8×25.4%—
Becton, Dickinson and Company🇺🇸$54.0 B57.4×4.2%+8.2%
Alcon Inc.🇨🇭$37.1 B37.9×9.4%+4.9%
ResMed Inc.🇺🇸$35.3 B22.1×27.8%+9.8%
West Pharmaceutical Services, Inc.🇺🇸$27.1 B42.4×18.8%+6.3%
Terumo Corporation🇯🇵$24.9 B27.0×12.0%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 28, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Employees:
As of June 30, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Pro-Dex, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Pro-Dex, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Pro-Dex, Inc.? Suggest a correction